Cheelcare (TSXV:CHER) Research & Development: C$0.38 Mil (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:CHER Cheelcare Inc TSXV:CHER
11 GF Score
Price C$1.73
! 3 Warning Signs
View Full Analysis

What is Cheelcare Research & Development?

Cheelcare TSXV:CHER +3.59% 11 Research & Development is C$0.38 Mil as of Jan. 2026. GuruFocus rates TSXV:CHER with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cheelcare's Research & Development for the three months ended in Jan. 2026 was C$0.05 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was C$0.38 Mil.

Cheelcare  (TSXV:CHER) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cheelcare Research & Development Related Terms

Cheelcare Research & Development Historical Data

* Premium members only.

The historical data trend for Cheelcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cheelcare Research & Development Chart

Cheelcare Annual Data
Trend Apr23 Apr24
Research & Development
0.13 0.14

Cheelcare Quarterly Data
Apr23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.00 0.16 0.17 0.05
TSXV:CHER
11GF Score
Cheelcare Inc TSXV:CHER
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cheelcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.38 Mil mean?
Cheelcare (TSXV:CHER) has a Research & Development of C$0.38 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Cheelcare and its competitors.
Is Cheelcare's Research & Development too high?
Cheelcare's current Research & Development is C$0.38 Mil. Overall, Cheelcare has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Cheelcare's Research & Development compare to ABT and SYK?
Cheelcare's Research & Development of C$0.38 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cheelcare and its competitors. Cheelcare's current Research & Development is C$0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cheelcare stock overvalued right now?
Cheelcare (TSXV:CHER) has a current Research & Development of C$0.38 Mil. The current Research & Development is C$0.38 Mil. Cheelcare's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cheelcare (TSXV:CHER), the current Research & Development is C$0.38 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cheelcare Business Description

Address 16 Sims Crescent, Unit 20, Richmond Hill, ON, CAN, L4B 2P1
Cheelcare Inc is a company that designs and manufactures inventive mobility devices using robotics. Its product portfolio consists of three key lines: Robotic Complex Rehab Power Wheelchair such devices feature patented self-leveling technology and the lowest seat-to-floor height in their class, enhancing stability and accessibility. Power Add-ons for Manual Wheelchairs designed to convert manual wheelchairs into powered mobility devices, offering users increased independence. Aftermarket Wheelchair Accessories includes a range of OEM equipment, backup cameras, phone chargers, and wheel suspension systems, that allow wheelchair users the ability to supplement their existing equipment to improve safety and convenience.
11GF Score

Get the complete analysis for TSXV:CHER

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.73
Price